LMO4 antibody (Middle Region)
Quick Overview for LMO4 antibody (Middle Region) (ABIN953196)
Target
See all LMO4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 107-135, Middle Region
-
Specificity
- This antibody recognizes Human and Mouse LMO4 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 107-135 amino acids from the Central region of human LMO4
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
-
: "LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells." in: American journal of cancer research, Vol. 8, Issue 4, pp. 594-609, (2018) (PubMed).
-
-
- LMO4 (LIM Domain Only 4 (LMO4))
-
Alternative Name
- LMO4
-
Background
- This gene encodes a cysteine-rich protein that contains two LIM domains but lacks a DNA-binding homeodomain. The encoded protein may play a role as a transcriptional regulator or as an oncogene.Synonyms: Breast tumor autoantigen, LIM domain only protein 4, LIM domain transcription factor LMO4, LMO-4, LMO4
-
Molecular Weight
- 17994 Da
-
Gene ID
- 8543
-
NCBI Accession
- NP_006760
-
Pathways
- Tube Formation
Target
-